Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian M Alexander

Showing results (21-30 of 159) with videos related to

Pageof 16
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapyBrian M Alexander, Megan Othus, Hale B Caglar, et al.
Expert Review of Neurotherapeutics|April 3, 2013
Current and future directions for Phase II trials in high-grade gliomaBrian M Alexander, Eudocia Q Lee, David A Reardon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2017
Designing Clinical Trials That Accept New Arms: An Example in Metastatic Breast CancerSteffen Ventz, Brian M Alexander, Giovanni Parmigiani, et al.
Nature Communications|February 16, 2022
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effectsDeborah Plana, Geoffrey Fell, Brian M Alexander, et al.
Neuro-Oncology|January 9, 2015
Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trialsLorenzo Trippa, Patrick Y Wen, Giovanni Parmigiani, et al.
Genes, Chromosomes & Cancer|December 4, 2002
A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly proteinDaniel S Wechsler, Lars D Engstrom, Brian M Alexander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2019
Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World DataSteffen Ventz, Albert Lai, Timothy F Cloughesy, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2016
The Radiation Oncology Job Market: The Economics and Policy of Workforce RegulationBenjamin P Falit, Hubert Y Pan, Benjamin D Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2019
Deviation from the Proportional Hazards Assumption in Randomized Phase 3 Clinical Trials in Oncology: Prevalence, Associated Factors, and ImplicationsRifaquat Rahman, Geoffrey Fell, Steffen Ventz, et al.
Neuro-Oncology|June 9, 2021
The use of external control data for predictions and futility interim analyses in clinical trialsSteffen Ventz, Leah Comment, Bill Louv, et al.
Pageof 16

Showing results (21-30 of 159) with videos related to

Sort By:
Pageof 16
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapyBrian M Alexander, Megan Othus, Hale B Caglar, et al.
Expert Review of Neurotherapeutics|April 3, 2013
Current and future directions for Phase II trials in high-grade gliomaBrian M Alexander, Eudocia Q Lee, David A Reardon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2017
Designing Clinical Trials That Accept New Arms: An Example in Metastatic Breast CancerSteffen Ventz, Brian M Alexander, Giovanni Parmigiani, et al.
Nature Communications|February 16, 2022
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effectsDeborah Plana, Geoffrey Fell, Brian M Alexander, et al.
Neuro-Oncology|January 9, 2015
Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trialsLorenzo Trippa, Patrick Y Wen, Giovanni Parmigiani, et al.
Genes, Chromosomes & Cancer|December 4, 2002
A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly proteinDaniel S Wechsler, Lars D Engstrom, Brian M Alexander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2019
Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World DataSteffen Ventz, Albert Lai, Timothy F Cloughesy, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2016
The Radiation Oncology Job Market: The Economics and Policy of Workforce RegulationBenjamin P Falit, Hubert Y Pan, Benjamin D Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2019
Deviation from the Proportional Hazards Assumption in Randomized Phase 3 Clinical Trials in Oncology: Prevalence, Associated Factors, and ImplicationsRifaquat Rahman, Geoffrey Fell, Steffen Ventz, et al.
Neuro-Oncology|June 9, 2021
The use of external control data for predictions and futility interim analyses in clinical trialsSteffen Ventz, Leah Comment, Bill Louv, et al.
Pageof 16